Clinical Trial Results: Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial reports pharmacokinetics of afamelanotide in patients with erythropoietic protoporphyria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria

Drugs mentioned

• Afamelanotide (afamelanotide)

Snippet

Sponsor: Clinuvel Europe Limited | Conditions: Erythropoietic Protoporphyria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-07-27